CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Convalescent Immune PlasmaWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (2)


Name (Synonyms) Correlation
drug272 Açaí palm berry extract - natural product Wiki 1.00
drug1822 Placebo Wiki 0.06

Correlated MeSH Terms (4)


Name (Synonyms) Correlation
D013577 Syndrome NIH 0.11
D055371 Acute Lung Injury NIH 0.10
D012127 Respiratory Distress Syndrome, Newborn NIH 0.10
D012128 Respiratory Distress Syndrome, Adult NIH 0.09

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Effectiveness of Convalescent Immune Plasma Therapy in Severe COVID-19 Patients With Acute Respiratory Distress Syndrome

The aim of the study is to evaluate the safety, improvement of clinical symptoms and laboratory parameters of convalescent immune plasma treatment in severe Covid-19 patients with ARDS.

NCT04442958 Acute Respiratory Distress Syndrome Other: Convalescent Immune Plasma
MeSH:Respiratory Distress Syndrome, Newborn Respiratory Distress Syndrome, Adult Acute Lung Injury Syndrome

Primary Outcomes

Description: Acute phase reactant

Measure: Plasma ferritin level

Time: 7. day

Description: Infection markers

Measure: Lymphocyte count

Time: 7. day

Description: Hypercoagulability

Measure: D-Dimer level

Time: 7. day

Description: Infection markers

Measure: C-Reactive protein level

Time: 7. day

Description: Infection markers

Measure: Plasma procalcitonin level

Time: 7. day

Description: Coagulopathy

Measure: Plasma fibrinogen level

Time: 7. day

Secondary Outcomes

Description: Arterial oxygenation

Measure: Fractional Inspired Oxygen Level

Time: 7. day

Description: Arterial oxygenation

Measure: Partial Oxygen Saturation level

Time: 7. day

Description: Arterial oxygenation

Measure: Arterial Oxygen level

Time: 7. day


No related HPO nodes (Using clinical trials)